Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133)

Clinical Biochemistry

Volumn 48, Issue 1-2, 2015, Pages 33-38

  Pradeepa, R ^a   Surendar, J ^a   Indulekha, K ^a   Chella, S ^a   Anjana, R M ^a   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

CURES; Diabetic retinopathy; Nephropathy; Neuropathy; Serum adiponectin; South Indians; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HALLUX; HUMAN; HYPERTENSION; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOTOGRAPHY; RADIOIMMUNOASSAY; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; URINARY EXCRETION; VIBRATION SENSE; BLOOD; COMPLICATION; DIABETIC ANGIOPATHY; INDIA; MIDDLE AGED; STATISTICAL MODEL;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84920269421     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.10.009     Document Type: Article

References (33)

1. Cusick M., Meleth A.D., Agrón E., Fisher M.R., Reed G.F., Knatterud G.L., et al. Early Treatment Diabetic Retinopathy Study Research Group. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 2005, 28:617-625.
2. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
3. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
4. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003, 16:72-75.
5. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103:1057-1063.
6. Ouchi N., Walsh K. A novel role for adiponectin in the regulation of inflammation. Arterioscler Thromb Vasc Biol 2008, 28:1219-1221.
7. Awazawa M., Ueki K., Inabe K., Yamauchi T., Kubota N., Kaneko K., et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 2011, 13:401-412.
8. Goldstein B.J., Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004, 89:2563-2568.
9. Yilmaz M.I., Sonmez A., Acikel C., et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004, 151:135-140.
10. Zietz B., Buechler C., Kobuch K., Neumeier M., Schölmerich J., Schäffler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2008, 116:532-536.
11. Higuchi A., Ohashi K., Kihara S., Walsh K., Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression. Circ Res 2009, 104:1058-1065.
12. Bora P.S., Kaliappan S., Lyzogubov V.V., et al. Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin. FEBS Lett 2007, 581:1977-1982.
13. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004, 316:165-169.
14. Bakkaloglu S.A., Soylemezoglu O., Buyan N., Funahashi T., Elhan A.H., Peru H., et al. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse. Pediatr Nephrol 2005, 20:474-477.
15. Jung C.H., Kim B.Y., Kim C.H., Kang S.K., Jung S.H., Mok J.O. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 2012, 11:24.
16. Deepa M., Pradeepa R., Rema M., Mohan A., Deepa R., Shanthirani S., et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-1). J Assoc Physicians India 2003, 51:863-870.
17. Alberti K.G., Zimmet P.Z. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
18. National High Blood Pressure Education Program The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7 Express 2003, 1-5.
19. Varghese A., Deepa R., Rema M., Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in Southern India. Postgrad Med J 2001, 77:399-402.
20. Rema M., Premkumar S., Anitha B., Deepa R., Pradeepa R., Mohan V. Prevalence of diabetic retinopathy in Urban India: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-1. Investig Ophthalmol Vis Sci 2005, 46:2328-2333.
21. Early Treatment of Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991, 98:786-806.
22. Pradeepa R., Rema M., Vignesh J., Deepa M., Deepa R., Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med 2008, 25:407-412.
23. Mohan V., Deepa R., Pradeepa R., Vimaleswaran K.S., Mohan A., Velmurugan K., et al. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005, 54:476-481.
24. Habeeb N.M., Youssef O.I., Saab A.A., El Hadidi E.S. Adiponectin as a marker of complications in type I diabetes. Indian Pediatr 2012, 49:277-280.
25. Kato K., Osawa H., Ochi M., Kusunoki Y., Ebisui O., Ohno K., et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol 2008, 68:442-449.
26. Imagawa A., Funahashi T., Nakamura T., Moriwaki M., Tanaka S., Nishizawa H., et al. Elevated ser um concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002, 25:1665-1666.
27. Perseghin G., Lattuada G., Danna M., Sereni L.P., Maffi P., De Cobelli F., et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003, 285:E1174-E1181.
28. Tomizawa A., Hattori Y., Kasai K., Nakano Y. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res 2008, 5:123-127.
29. Diabetes Control and Complications Trial Research Group Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997, 46:1829-1839.
30. Kacso I., Lenghel A., Bondor C.I., Moldovan D., Rusu C., Nita C., et al. Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients. Int Urol Nephrol 2012, 44:1151-1157.
31. Saraheimo M., Forsblom C., Fagerudd J., et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005, 28:1410-1414.
32. Kollerits B., Fliser D., Heid I.M., et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 2007, 71:1279-1286.
33. Herder C., Lankisch M., Ziegler D., Rathmann W., Koenig W., Illig T., et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care 2009, 32:680-682.